IO Biotech (IOBT) News Today $1.29 -0.05 (-3.73%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 25 at 6:21 PM | markets.businessinsider.comIO Biotech Announces New Head and Neck Cohort Data Accepted for Presentation at ESMO Congress 2024July 21, 2024 | finance.yahoo.comIO Biotech, Inc.'s (NASDAQ:IOBT) market cap touched US$104m last week, benefiting both private equity firms who own 59% as well as institutionsJuly 14, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Down 17.6% in JuneIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 90,700 shares, a drop of 17.6% from the June 15th total of 110,100 shares. Based on an average trading volume of 102,800 shares, the short-interest ratio is currently 0.9 days. Approximately 0.2% of the shares of the stock are sold short.July 5, 2024 | marketbeat.comIO Biotech (NASDAQ:IOBT) Stock Price Down 4.2%IO Biotech (NASDAQ:IOBT) Trading Down 4.2%July 4, 2024 | investorplace.com3 Undervalued Biotech Gems With 200%+ Analyst Price TargetsJune 13, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 129.4% in MayIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 92,200 shares, a growth of 129.4% from the May 15th total of 40,200 shares. Based on an average daily volume of 98,200 shares, the days-to-cover ratio is presently 0.9 days. Approximately 0.2% of the company's stock are sold short.May 27, 2024 | finance.yahoo.comWill IO Biotech (NASDAQ:IOBT) Spend Its Cash Wisely?May 23, 2024 | globenewswire.comIO Biotech to Present at Jefferies Global Healthcare ConferenceMay 17, 2024 | marketbeat.comResearch Analysts Offer Predictions for IO Biotech, Inc.'s Q2 2024 Earnings (NASDAQ:IOBT)IO Biotech, Inc. (NASDAQ:IOBT - Free Report) - Equities research analysts at HC Wainwright upped their Q2 2024 earnings per share estimates for IO Biotech in a research note issued on Wednesday, May 15th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings per shareMay 15, 2024 | markets.businessinsider.comOptimistic Buy Rating for IO Biotech Amidst Promising Clinical Trial Progress and Accelerated PFS Data TimelineMay 15, 2024 | marketbeat.comHC Wainwright Boosts IO Biotech (NASDAQ:IOBT) Price Target to $12.00HC Wainwright increased their price objective on shares of IO Biotech from $8.00 to $12.00 and gave the company a "buy" rating in a research report on Wednesday.May 15, 2024 | insidertrades.comInsider Selling: IO Biotech, Inc. (NASDAQ:IOBT) Major Shareholder Sells 658,809 Shares of StockMay 15, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Major Shareholder Holdings A/S Novo Sells 658,809 SharesIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) major shareholder Holdings A/S Novo sold 658,809 shares of the business's stock in a transaction dated Friday, May 10th. The shares were sold at an average price of $1.22, for a total value of $803,746.98. Following the completion of the transaction, the insider now directly owns 4,429,449 shares of the company's stock, valued at $5,403,927.78. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.May 14, 2024 | investorplace.comIOBT Stock Earnings: IO Biotech Beats EPS for Q1 2024May 14, 2024 | globenewswire.comIO Biotech Reports First Quarter 2024 Financial Results and Provides Business HighlightsMay 12, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Sees Significant Drop in Short InterestIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a significant drop in short interest in the month of April. As of April 30th, there was short interest totalling 39,500 shares, a drop of 36.1% from the April 15th total of 61,800 shares. Based on an average daily volume of 135,000 shares, the short-interest ratio is presently 0.3 days. Currently, 0.1% of the shares of the company are sold short.April 29, 2024 | marketbeat.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 9.4%IO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 61,800 shares, a decline of 9.4% from the March 31st total of 68,200 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily trading volume, of 133,900 shares, the days-to-cover ratio is currently 0.5 days.April 24, 2024 | globenewswire.comIO Biotech Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 17, 2024 | msn.comIO Biotech (IOBT) Price Target Decreased by 11.11% to 8.16April 15, 2024 | globenewswire.comIO Biotech Expands Senior Leadership Team to Progress Commercialization ReadinessApril 11, 2024 | investing.comIO Biotech presents cancer vaccine data at AACRApril 9, 2024 | globenewswire.comIO Biotech Presents New Data at AACR 2024 Further Supporting Dual Mechanism of Action of Lead Cancer Vaccine, IO102-IO103April 5, 2024 | globenewswire.comIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business OfficerMarch 29, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest Up 50.3% in MarchIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 81,600 shares, a growth of 50.3% from the February 29th total of 54,300 shares. Based on an average daily trading volume, of 144,900 shares, the days-to-cover ratio is presently 0.6 days. Approximately 0.2% of the shares of the stock are sold short.March 18, 2024 | marketbeat.comShort Interest in IO Biotech, Inc. (NASDAQ:IOBT) Rises By 10.4%IO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 29th, there was short interest totalling 54,300 shares, a growth of 10.4% from the February 14th total of 49,200 shares. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily volume of 148,200 shares, the days-to-cover ratio is currently 0.4 days.March 11, 2024 | marketbeat.comAnalysts Offer Predictions for IO Biotech, Inc.'s Q1 2024 Earnings (NASDAQ:IOBT)IO Biotech, Inc. (NASDAQ:IOBT - Free Report) - Stock analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for IO Biotech in a research note issued to investors on Wednesday, March 6th. HC Wainwright analyst E. Bodnar expects that the company will earn ($0.38) per share forMarch 7, 2024 | finance.yahoo.comIO Biotech Inc (IOBT) Reports Year-End Financial Results and Progress in Clinical TrialsMarch 6, 2024 | markets.businessinsider.comBuy Recommendation for IO Biotech on Strong Data Prospects and Undervalued Stock PositionMarch 6, 2024 | morningstar.comIO Biotech Inc IOBTMarch 6, 2024 | msn.comIO Biotech GAAP EPS of -$0.40 misses by $0.02March 6, 2024 | globenewswire.comIO Biotech Announces Acceptance of Abstract to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingMarch 6, 2024 | marketbeat.comIO Biotech (NASDAQ:IOBT) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $8.00 price target on shares of IO Biotech in a research report on Wednesday.March 5, 2024 | investorplace.comIOBT Stock Earnings: IO Biotech Misses EPS for Q4 2023March 5, 2024 | globenewswire.comIO Biotech Announces 2023 Fourth-Quarter and Year-End ResultsMarch 3, 2024 | marketbeat.comArmistice Capital LLC Buys New Shares in IO Biotech, Inc. (NASDAQ:IOBT)Armistice Capital LLC bought a new stake in shares of IO Biotech, Inc. (NASDAQ:IOBT - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,148,000 shares of the company's stock, valued at apFebruary 26, 2024 | globenewswire.comIO Biotech to Present at 44th Annual Cowen Health Care ConferenceFebruary 6, 2024 | marketbeat.comVivo Capital LLC Has $8.71 Million Stake in IO Biotech, Inc. (NASDAQ:IOBT)Vivo Capital LLC grew its holdings in shares of IO Biotech, Inc. (NASDAQ:IOBT - Free Report) by 104.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 6,173,439 shares of the company's stock afFebruary 4, 2024 | msn.comWhat's Next for Iovance Biotherapeutics Stock?January 15, 2024 | finance.yahoo.comIO Biotech, Inc. (NASDAQ:IOBT) most popular amongst private equity firms who own 61% of the shares, institutions hold 24%January 3, 2024 | marketbeat.comIO Biotech, Inc. (NASDAQ:IOBT) Short Interest UpdateIO Biotech, Inc. (NASDAQ:IOBT - Get Free Report) was the recipient of a significant decrease in short interest in the month of December. As of December 15th, there was short interest totalling 185,500 shares, a decrease of 7.7% from the November 30th total of 200,900 shares. Currently, 0.5% of the company's shares are short sold. Based on an average daily trading volume, of 126,000 shares, the days-to-cover ratio is currently 1.5 days.January 3, 2024 | seekingalpha.comIO Biotech: A Phase 3 Company Getting No RespectDecember 21, 2023 | finance.yahoo.comIO Biotech Announces First Patient Dosed in Phase 2 Neoadjuvant/Adjuvant Solid Tumor Basket TrialDecember 19, 2023 | finance.yahoo.comWe're Keeping An Eye On IO Biotech's (NASDAQ:IOBT) Cash Burn RateNovember 27, 2023 | msn.comIO Biotech executive discloses purchase of 10K sharesNovember 24, 2023 | seekingalpha.comIOBT IO Biotech, Inc.November 15, 2023 | investing.comIO Biotech earnings beat, revenue was in line with estimatesNovember 15, 2023 | markets.businessinsider.comPromising Clinical Trials and Favorable Safety Profile Drives Buy Rating for IO BiotechNovember 14, 2023 | benzinga.comIO Biotech Stock (NASDAQ:IOBT) Earnings Dates and Earning CallsNovember 13, 2023 | msn.comIO Biotech GAAP EPS of -$0.43 misses by $0.10November 13, 2023 | benzinga.comIO Biotech: Q3 Earnings Insights Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Top Stock Unveiled! (Ad)Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time. Get Your Free Report IOBT Media Mentions By Week IOBT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IOBT News Sentiment▼0.990.62▲Average Medical News Sentiment IOBT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IOBT Articles This Week▼31▲IOBT Articles Average Week Get IO Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for IOBT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: aTyr Pharma News Today DURECT News Today Enanta Pharmaceuticals News Today MacroGenics News Today Kamada News Today ADC Therapeutics News Today Zentalis Pharmaceuticals News Today Amarin News Today Atea Pharmaceuticals News Today Cartesian Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IOBT) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IO Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IO Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.